Selective COX2 inhibitors also seem to be effective for prevention of sporadic adenomatous polyps, as they significantly reduced the occurrence of colorectal adenomas within 3 years after polypectomy (Arber et al, 2006). The gene discussed is PTGS2; the disease is colorectal adenoma.